Nd\u00ebrmarrja farmaceutike ruse “R-Pharm” <\/p>\n\n\n\n
(nj\u00eb nga kompanit\u00eb m\u00eb t\u00eb m\u00ebdha farmaceutike n\u00eb Rusi), <\/p>\n\n\n\n
paraqiti nje k\u00ebrkes\u00eb p\u00ebr patent\u00eb nd\u00ebrkomb\u00ebtare t\u0451 medikamentit kund\u00ebr koronavirusit
M\u00eb 29 Mars 2020, <\/p>\n\n\n\n
\u201cR-Pharm\u201d, paraqiti aplikacionin e par\u00eb p\u00ebr patent\u00eb nd\u00ebrkomb\u00ebtare p\u00ebr p\u00ebrgatitjen bioteknologjike q\u00eb lidh grimcat virale dhe parandalon hyrjen e tyre n\u00eb alveolit.<\/p>\n\n\n\n
Sipas Alexey Repik, Kryetar i Bordit t\u00eb Drejtor\u00ebve, projekti i zhvillimit t\u00eb ila\u00e7eve \u00ebsht\u00eb n\u00eb nj\u00eb faz\u00eb t\u00eb hershme, por \u00ebsht\u00eb nj\u00eb prioritet dhe po p\u00ebrparohet n\u00eb nj\u00eb m\u00ebnyr\u00eb t\u00eb p\u00ebrshpejtuar.<\/p>\n\n\n\n
\u201cNe presim q\u00eb, s\u00eb bashku me metodat e tjera premtuese t\u00eb trajtimit, molekula e re do t\u00eb jet\u00eb n\u00eb gjendje t\u00eb kontribuoj\u00eb n\u00eb luft\u00ebn kund\u00ebr infeksionit t\u00eb koronavirusit n\u00eb Rusi dhe n\u00eb bot\u00eb, “tha Repik.
Kompania farmaceutike e teknologjis\u00eb s\u00eb lart\u00eb ruse “specializohet n\u00eb zhvillimin, prodhimin dhe komercializimin e ila\u00e7eve t\u00eb teknologjis\u00eb s\u00eb lart\u00eb, pajisjeve laboratorike dhe pajisjeve mjek\u00ebsore. Grupi operon n\u00eb Federat\u00ebn Ruse, si dhe n\u00eb vendet e ish Bashkimit Sovjetik, SHBA, Gjermani dhe Japoni
Sipas t\u00eb dh\u00ebnave m\u00eb t\u00eb fundit t\u00eb Organizat\u0451s Bot\u00ebrore t\u0451 Sh\u00ebndetit, m\u00eb shum\u00eb se 634 mij\u00eb raste jan\u00eb regjistruar n\u00eb bot\u00eb t\u0451 prekur nga koronavirus dhe pothuajse 30 mij\u00eb njer\u00ebz kan\u00eb vdekur.<\/p>\n\n\n\n
Pergatiti: Blerina Mahmutaj<\/p>\n","protected":false},"excerpt":{"rendered":"
Nd\u00ebrmarrja farmaceutike ruse “R-Pharm” (nj\u00eb nga kompanit\u00eb m\u00eb t\u00eb m\u00ebdha farmaceutike n\u00eb Rusi), paraqiti nje k\u00ebrkes\u00eb p\u00ebr patent\u00eb nd\u00ebrkomb\u00ebtare t\u0451 medikamentit kund\u00ebr koronavirusit M\u00eb 29 Mars 2020, \u201cR-Pharm\u201d, paraqiti aplikacionin e par\u00eb p\u00ebr patent\u00eb nd\u00ebrkomb\u00ebtare p\u00ebr p\u00ebrgatitjen bioteknologjike q\u00eb lidh grimcat virale dhe parandalon hyrjen e tyre n\u00eb alveolit. Sipas Alexey Repik, Kryetar i Bordit […]<\/p>\n","protected":false},"author":5,"featured_media":24767,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[2858],"class_list":["post-24766","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktualitet","tag-virus"],"_links":{"self":[{"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/posts\/24766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/comments?post=24766"}],"version-history":[{"count":0,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/posts\/24766\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/media\/24767"}],"wp:attachment":[{"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/media?parent=24766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/categories?post=24766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/intervista.al\/web\/wp-json\/wp\/v2\/tags?post=24766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}